Barclays’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-473,077
| Closed | -$2.02M | – | 7171 |
|
|
2019
Q3 | $2.02M | Buy |
473,077
+413,885
| +699% | +$1.5M | ﹤0.01% | 2850 |
|
|
2019
Q2 | $176K | Sell |
59,192
-95,921
| -62% | -$240K | ﹤0.01% | 5232 |
|
|
2019
Q1 | $270K | Sell |
155,113
-231,255
| -60% | -$320K | ﹤0.01% | 4598 |
|
|
2018
Q4 | $325K | Buy |
+386,368
| New | +$461K | ﹤0.01% | 4213 |
|
|
2018
Q3 | – | Sell |
-171,993
| Closed | -$142K | – | 7601 |
|
|
2018
Q2 | $142K | Buy |
171,993
+150,762
| +710% | +$145K | ﹤0.01% | 5016 |
|
|
2018
Q1 | $29K | Buy |
21,231
+5,061
| +31% | +$5.88K | ﹤0.01% | 6276 |
|
|
2017
Q4 | $16K | Buy |
16,170
+13,807
| +584% | +$15.6K | ﹤0.01% | 6391 |
|
|
2017
Q3 | $4K | Sell |
2,363
-7,100
| -75% | -$11.9K | ﹤0.01% | 6545 |
|
|
2017
Q2 | $17K | Buy |
9,463
+9,180
| +3,244% | +$12.2K | ﹤0.01% | 5882 |
|
|
2017
Q1 | $0 | Sell |
283
-750
| -73% | -$611 | ﹤0.01% | 7114 |
|
|
2016
Q4 | $1K | Buy |
1,033
+689
| +200% | +$580 | ﹤0.01% | 6539 |
|
|
2016
Q3 | $0 | Buy |
+344
| New | +$460 | ﹤0.01% | 6912 |
|
|
2016
Q2 | – | Sell |
-48
| Closed | – | – | 6790 |
|
|
2016
Q1 | $0 | Buy |
+48
| New | +$82 | ﹤0.01% | 6596 |
|
|
2015
Q4 | – | Sell |
-117
| Closed | – | – | 6882 |
|
|
2015
Q3 | $0 | Sell |
117
-314
| -73% | -$1.13K | ﹤0.01% | 7182 |
|
|
2015
Q2 | $1K | Buy |
+431
| New | +$1.84K | ﹤0.01% | 6950 |
|
Barclays's CVRS Position: Q4 2019 in Review
Barclays sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2019, closing a stake of 473,077 shares — an estimated $2.02M sold.
Barclays first reported a position in CVRS in Q2 2015 and held it in 15 quarters. The position peaked at $2.02M in Q3 2019. 0 funds tracked by Wall St. Rank hold CVRS as of Q4 2019.
- Barclays reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2019 after selling out during the quarter.
- Barclays sold 473,077 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2019, an estimated $2.02M.
- Barclays first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2015 and held it in 15 quarters.
- Barclays's CORINDUS VASCULAR ROBOTICS, INC position peaked at $2.02M in Q3 2019.
- 0 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2019.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.